Philips (PHG) Reports Q1 Adjusted EPS

On May 6, 2026, Koninklijke Philips N.V. (NYSE:PHG) reported Q1 adjusted EPS of EUR 0.23 compared to EUR 0.25 past year. Revenue totaled EUR 3.91B compared to EUR 4.1B successful the prior-year period. The institution said it delivered a coagulated commencement to 2026, with bid intake maturation of 6%, comparable income maturation of 4%, and adjusted EBITDA borderline enlargement of 40 ground points, supported by disciplined execution contempt an uncertain macroeconomic backdrop. Philips added that income maturation was driven by North America and Europe and spanned each operating segments.

The institution besides said it is advancing a caller strategy focused connected accelerating profitable maturation done segment-specific priorities, platform-based innovation, and operational discipline. Philips highlighted respective AI-related developments during the quarter, including regulatory support for SmartHeart, which automates cardiac MRI planning, and DeviceGuide, which adds AI-powered real-time guidance to cardiac procedures connected the Azurion platform. Philips besides pointed to continued request for its OneBlade grooming platform.

Koninklijke Philips N.V. (NYSE:PHG) maintained its FY26 outlook for comparable income maturation of 3%-4.5%, adjusted EBITDA borderline of 12.5%-13%, and escaped currency travel of EUR 1.3 B-EUR 1.5 B. The institution said its outlook incorporates presently known tariff impacts and broader macroeconomic uncertainty but excludes immoderate imaginable International Emergency Economic Powers Act tariff refunds and ongoing Philips Respironics-related ineligible proceedings.

Last month, Koninklijke Philips N.V. (NYSE:PHG) announced it received FDA 510(k) clearance for its Rembra imaging platform, including the Rembra CT, Rembra RT, and Areta RT systems. The institution said the systems are designed to assistance healthcare providers amended imaging and radiation therapy readying ratio arsenic request and objective complexity proceed to increase.

Koninklijke Philips N.V. (NYSE:PHG) operates arsenic a wellness exertion institution serving markets crossed North America, Greater China, and internationally.

While we admit the imaginable of PHG arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.